Variant report
Variant | esv3483393 |
---|---|
Chromosome Location | chr9:43313756-43318154 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs143902925 | chr9:43314006-43314007 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs182629468 | chr9:43314007-43314008 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs587625966 | chr9:43314011-43314012 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs587683475 | chr9:43314029-43314030 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs587762052 | chr9:43314035-43314036 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs146496920 | chr9:43314047-43314048 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs587720482 | chr9:43314049-43314050 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs139158244 | chr9:43314058-43314059 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs587643334 | chr9:43314062-43314063 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs587710892 | chr9:43314067-43314068 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs587605586 | chr9:43314068-43314069 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs111979477 | chr9:43314083-43314084 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs373659365 | chr9:43314104-43314105 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs28552539 | chr9:43314125-43314126 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs587662135 | chr9:43314134-43314135 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs587742134 | chr9:43314160-43314161 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs587621107 | chr9:43314163-43314164 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs373415998 | chr9:43314184-43314185 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs587730168 | chr9:43314198-43314199 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs73648327 | chr9:43314201-43314202 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs28668662 | chr9:43314207-43314208 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs587728946 | chr9:43314220-43314221 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs587616891 | chr9:43314221-43314222 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs113790172 | chr9:43314251-43314252 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs386734653 | chr9:43314263-43314264 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs587683458 | chr9:43314283-43314284 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs587743023 | chr9:43314294-43314295 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs28464966 | chr9:43314341-43314342 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs587618287 | chr9:43314348-43314349 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs373266743 | chr9:43314349-43314350 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs191964235 | chr9:43314350-43314351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs28657516 | chr9:43314352-43314353 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs587683241 | chr9:43314368-43314369 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs587767028 | chr9:43314371-43314372 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs148585672 | chr9:43314373-43314374 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs587747903 | chr9:43314374-43314375 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs587619318 | chr9:43314390-43314391 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs587677200 | chr9:43314406-43314407 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs587716854 | chr9:43314414-43314415 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs115069136 | chr9:43314431-43314432 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs371279712 | chr9:43314434-43314435 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs371583730 | chr9:43314448-43314449 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs185585686 | chr9:43314456-43314457 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs587722180 | chr9:43314475-43314476 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs373065244 | chr9:43314489-43314490 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs28561522 | chr9:43314508-43314509 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
47 | rs201613679 | chr9:43314510-43314511 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs587618042 | chr9:43314523-43314524 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs28420826 | chr9:43314525-43314526 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs587695204 | chr9:43314533-43314534 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17133270 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Cancer | 20164919 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 22183965 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Cancer | 16751803 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Oral cancer | 21386901 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21509527 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Breast cancer | 20409316 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Schizophrenia | 21346763 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 21990379 | CNVD |
Astrocytoma | 22246337 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:43314000-43314200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
2 | chr9:43314000-43314800 | Enhancers | Fetal Brain Male | brain |
3 | chr9:43314400-43315400 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
4 | chr9:43314800-43315800 | Weak transcription | Fetal Brain Male | brain |
5 | chr9:43315400-43316000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
6 | chr9:43315400-43316000 | Enhancers | NHEK | skin |
7 | chr9:43316000-43316200 | Enhancers | Fetal Brain Male | brain |